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Background: Carbohydrate-deficient transferrin (CDT) is a widely used alcohol biomarker. Because of the high
prevalence of chronic alcohol abuse in many countries, CDT plays an important role in the areas of traffic, clinical,
and forensic medicine. However, CDT levels have not been determined in the Han Chinese population. Therefore,
we investigated the frequency of genetic transferrin variants and the relationship between CDT levels and alcohol
consumption in this population. From this data, we established a CDT cut-off for Han Chinese and evaluated the
analytical performance of the CDT capillary zone electrophoresis system.
Results: The prevalence of transferrin variants was 4.14%. The mean CDT level of the reference group was 0.73%.
We recommended CDT level >1.5% as cut off standard of alcohol intake to ensuring the specificity was best. The
CDT test total precision for 0.5%, 0.7%, and 1.55% was 14.4%, 11.5%, and 7.2%, respectively. The data showed good
linearity in the studied range of 0.6% to 8.2%.
Conclusions: These results demonstrate that CDT is a useful marker to detect heavy daily alcohol consumption. We
proposed and evaluated the first CDT cut-off for the Han Chinese population, and we showed that the CDT capillary
zone electrophoresis system is a reliable analytic method.
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Alcohol abuse is common throughout the world. Alcohol-
ism causes neurological and psychiatric damage, as well as
other somatic disorders. Alcohol is also regarded as one of
the most dangerous factors in traffic accidents. The bio-
logical, clinical, and social effects of alcohol abuse high-
light the urgent need for objective and specific markers
for alcohol-related diseases and for early detection of
potential alcohol abusers. Laboratory markers of alcohol
consumption can play an important role in identifying
alcohol intake. However, the traditional biomarkers of al-
cohol abuse, such as gamma glutamyl transferase (GGT),
mean corpuscular volume (MCV), alanine transaminase
(ALT) and aspartate transaminase (AST), have variable
and limited sensitivity and specificity [1]. Therefore, more
attention has been paid to new alcohol markers, especially
carbohydrate-deficient transferrin (CDT).
CDT refers to the less sialylated forms of human trans-
ferrin: asialo- and disialo-transferrin (which lack one or* Correspondence: guo.wei@zs-hospital.sh.cn
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unless otherwise stated.two complete N-glycans) [2]. It is assumed that alcohol
intake ≥50–80 g/day for a period of at least two weeks
leads to increased concentrations of CDT [3]. Although
the mechanism remains unknown, a large number of
studies indicate that CDT is a good biomarker for the
diagnosis of heavy alcohol consumption, with higher
sensitivity and specificity than any of the other conven-
tional markers [4-7].
Since its discovery in 1976 [8], CDT has quickly become
the focus of basic research and clinical studies. Numerous
studies have shown that there is a close correlation be-
tween CDT levels and alcohol consumption, and the US
Food and Drug Administration approved CDT as a bio-
marker to assess alcohol intake in 2001 [2]. Currently,
CDT is recognized as an independent alcohol marker, with
reliable sensitivity and specificity to identify heavy drinking
[9]. For over 4.5 years, it has been used in traffic medicine
among subjects applying for driver’s license renewal or
regranting in Belgium [10]. In addition to effectively esti-
mating alcohol consumption, CDT also provides a novel
tool to diagnose alcohol-related diseases. Today, CDT has
clinical, forensic, and judicial applications. Approximatelytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 CDT levels and daily alcohol intake data for
all subjects.
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lished, but CDT levels have never been determined in the
Han Chinese population. Given the different alcohol cus-
toms in China and the West, we aim to establish a CDT
cut-off for the Han Chinese population.
Results
Normal value of CDT
The nondrinkers and light/moderate drinkers were used
to investigate normal CDT values. Table 1 presents CDT
values grouped according to gender and three age groups.
There was a statistically significant difference between the
genders (P = 0.00, <0.05), with male CDT values being
higher than those of females in every age group. The dif-
ferences among the three groups were P = 0.62 for males
and P = 0.03 for females. The difference for females be-
tween the 0–40-year group and the 41–60-year group
were also significant (P = 0.02, <0.05).
Genetic variants of transferrin
Among our original 797 subjects, 33 individuals (4.14%)
had genetic variants of transferrin (B or D variants).
These variants were detected by capillary electrophor-
esis, but this method cannot identify the exact type of B
or D variant. We also used CDT-IS as a control to ex-
clude false genetic CDT variants caused by monoclonal
immunoglobulins in the beta zone. All of the variant re-
sults could not be incorporated into the statistical
analysis.
The relationship between CDT levels and alcohol
consumption
The relationship between CDT values and daily alcohol
intake is shown in Figure 1. Among nondrinkers, CDT
values ranged from 0.2% to 1.6%. For drinkers, the low-
est CDT value was 0.5% (with a daily alcohol intake of
5 g) and the highest was 6.3% (with a daily alcohol con-
sumption of 240 g).
Based on alcohol consumption, the population was di-
vided into six subgroups. The alcohol consumption and
CDT values of all subjects are presented in Table 2. WithTable 1 Non-heavy drinkers divided into 6 groups
0-40y 41-60y 61-80y
Male (n = 299)
Number 115 126 58
Mean CDT (%) 0.76 0.75 0.78
CDT SD 0.18 0.18 0.17
P 0.82 0.33
Female (n = 387)
Number 147 185 55
Mean CDT (%) 0.73 0.68 0.73
CDT SD 0.16 0.18 0.17
P 0.02* 0.09
*The results of statistics analysis between subgroup appear significant.increasing daily mean alcohol intake, the CDT values
raised gradually. This phenomenon was not statistically
significant for daily alcohol intake ≤45 g but showed sig-
nificance when alcohol consumption exceeded this value.
A difference of mean %CDT was observed between sub-
groups 4 and 5 (P = 0.04, <0.05), and between subgroups
5 and 6 (P = 0.000, <0.05). Such a variation in consecu-
tive subgroups only existed between these subgroups.
CDT cut-off
We proposed a CDT cut-off of 1.5%, based on the 95th
percentile value of drinkers [11]. To evaluate the sensitiv-
ity and specificity of the chosen cut-off, receiver operating
characteristic (ROC) curves were generated (Figure 2 and
Table 3). The area under the ROC curves was largest for
the group with alcohol consumption of 60 g/day or more.
The cut-off value showed great specificity, but the sensitiv-
ity was far from ideal.
Precision
The results of the precision studies are shown in Table 4.
The intra-run and between-day precision of three serum
pools is presented. The maximum discrepancy in the
intra-run precision study was 0.2%, 0.1%, and 0.2% for
P1, P2, and P3, respectively. Thus, the repeatability of
the system for routine testing is acceptable.
Linearity
In the linearity experiment, the measured CDT values
were similar to the calculated values, with a correlation
coefficient of 0.997. The slope of first-order polynomial
significantly differed from 0.0 (P = 0.000). The slopes of
second-order and third-order polynomials also showed
statistically significant differences from 0.0 (P = 0.450
and 0.500, respectively). The CDT detection by the
measurement system was linear in the studied range of
0.6% to 8.2%.
Table 2 Alcohol consumption and %CDT data
Subgroup 1 2 3 4 5 6
(Alcohol g/day) 0 ≤15 16-30 31-45 46-60 >60
Number (M-W) 623 (243-380) 31 (26-5) 32 (30-2) 28 (25-3) 28 (26-2) 22 (22-0)
Mean alcohol intake 0.00 9.20 22.80 39.20 55.90 133.40
%CDT mean 0.73 0.75 0.80 0.85 0.90 2.34
%CDT range 0.20-1.60 0.50-1.00 0.60-1.00 0.70-1.10 0.70-1.30 1.00-6.30
P 0.59 0.10 0.09 0.04* 0.00*
*The results of statistics analysis between subgroup appear significant.
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Our study used the first large-scale abstinent group to
investigate normal CDT values in Han Chinese. The
mean CDT value of all non-heavy drinkers was 0.73%.
Although the causes remain unknown, our data revealed
a small statistically significant difference between gen-
ders. The mean CDT value was higher in males than in
females. A small statistically significant difference was
observed between the various age groups in females but
not in males. This finding seems to be consistent with
the report by Bergström and Helander [12]. In Jonas P
and Anders H study [13], the upper reference limit was
set at 1.7%, which is higher than our proposed CDT cut-off
of 1.5%. These differences may be due to the measure-
ment systems (high-performance liquid chromatography
[HPLC], vs. capillary electrophoresis) and target subjects
(Western vs. Asian populations). Many factors influence
CDT values, including atypical phenotype distributions of
alcohol dehydrogenase [14], amount of daily alcohol con-
sumption, amount of alcohol consumed per drinking ses-
sion, duration of abstinence before blood sampling, body
weight [15] and consumption of fermented food. All these
factors may contribute to the CDT differences between
Han Chinese and other populations.
Our study is the first to report the frequency of
transferrin variants in a large Han Chinese population.Figure 2 Receiver operating characteristic curves of %CDT accordingGenetic transferrin variants result from amino acids sub-
stitutions in the polypeptide chain [16]. Most individuals
express allele C, but at least 38 transferrin variants have
been found [17]. Although only four isoforms show a
prevalence of >1%, transferrin variants can interfere with
CDT analysis because of their similar isoelectric points
(pIs). transferrin-D can cause false positive results for
non-abusers [18], and transferrin-B can cause false nega-
tive results for chronic alcohol abusers [2]. These vari-
ants can be detected by capillary electrophoresis and
HPLC, avoiding with inaccurate CDT calculations. It has
been reported that the frequency of genetic transferrin
variants is low in Caucasians (<1%) but high in African
Americans, Africans, and natives of South America
[19,20]. However, there was no precise data for the Han
Chinese population. In our study of Han Chinese, 33 of
797 individuals (4.14%) had a transferrin-B or transferrin-
D genetic variant.
We also analyzed the correlation between CDT values
and alcohol consumption. Some studies found an in-
crease in CDT serum concentrations after sustained al-
cohol consumption of 50–80 g/day for at least one
week, but other reports showed an increase in CDT
values after 4–6 times the standard alcohol consumption
for at least two weeks [21]. CDT values slowly normalize
during periods of abstinence. Although there is a clearto each target amount of daily alcohol consumption.
Table 3 Sensitivities and specificities of 1.5% as cut-off
Different amount of alcohol consumption (%)
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take, it remains unclear how CDT values should be used
to diagnose alcohol abuse. For instance, it is unclear
whether we can extrapolate alcohol consumption (espe-
cially moderate alcohol intake of 10–20 g/day) according
to CDT values. Table 3 shows that the proportion of in-
dividuals in subgroups 2 (<15 g/day), 3 (15–30 g/day),
and 4 (31–45 g/day) whose CDT values are below the
CDT cut-off is nearly 91%, 85%, and 62%, respectively.
Ninety five percent of the group with daily ethanol in-
take above 60 g/day have CDT levels higher than 1.5%,
suggesting that this cut-off can be used to confirm re-
cent drinking behavior. We found a significant threshold
in CDT values between subgroups 4 and 5 (P < 0.05)
(Table 3), suggesting that CDT levels are sensitive to
high alcohol intake, such as more than 60 g/day. We
found no correlation between CDT values and years of
sustained drinking (data not shown). In the Figure 2, re-
ceiver operating characteristic curves of CDT according
to each target amount of daily alcohol consumption
were carried out. The area under ROC curves was best
in the alcohol consumption ≥ 60 g/day group. When set-
ting cut-off as 1.5%, the specificities were all above 90%.
However, the sensitivities were far from ideal (Table 4).
To avoid the numerous biases that can be made during
the diagnosis of alcoholism, evaluating CDT with other
biomarkers has been recommended.
Furthermore, we evaluated the analytic performance of
the Sebia capillary electrophoresis measurement system.
The precision and linearity studies showed excellent re-
sults. CDT measurements require high precision (espe-
cially near the cut-off value) for clinical and forensic
applications. Compared with the other studies, our re-
sults of total CV were high. This might be because we
selected the lower values of CDT serum pools, and ourTable 4 Precision of %CDT using capillary electrophoresis
on three different serum pools
Mean CDT (%) Intra-run precision Between day Total precision
SD (CV%) SD CV (%) CV (%)
P1 0.50 0.04 (8.00%) 0.06 (12.00%) 14.41
P2 0.70 0.04 (5.70%) 0.07 (10.00%) 11.52
P3 1.55 0.05 (3.20%) 0.10 (6.50%) 7.20lack of high value CDT serum pools could be a draw-
back of our study.
Conclusions
Previous studies have shown that CDT values provide a
diagnostic tool to estimate heavy ethanol consumption,
especially daily intake over 45 g. Nonetheless, few stud-
ies have been conducted to assess this marker in the
Chinese population. We evaluated the frequency of gen-
etic transferrin variants, determined the CDT normal
range, and proposed a CDT cut-off from a large Chinese
population. Further studies focusing on heavy alcoholics
in the Chinese population are needed.
Methods
Study population
In total, 718 adults (340 males aged 17 to 85 years and 378
females aged 19 to 85 years) were recruited from five
Shanghai communities from July to November 2010. Be-
cause CDT levels can be influenced by alcohol-independent
factors, the following exclusion criteria were used for
the abstinent reference population: presence of liver dis-
ease (such as hepatitis or cancer), autoimmune liver dis-
ease (such as primary biliary cirrhosis), end-stage liver
disease, previous liver surgery, liver trauma, and preg-
nancy. This study was performed with permission from
the Ethical Committee of Zhongshan Hospital of Fudan
University (Shanghai, China), and written consent was ob-
tained from all participants. The subjects were interviewed
about any history of alcoholism and their daily drinking
habits (with regard to both the type and amount of alco-
hol). Simultaneously, 79 surplus samples from subjects
with a clinical diagnosis of alcohol disease were obtained
from our laboratory to enlarge the non-abstinent group,
and these subjects reported their alcohol intake using the
same questionnaires. All questionnaires were appropri-
ately preserved. A total of 33 individuals with genetic vari-
ants of transferrin were excluded to give a total study
population of 764.
According to the World Health Organization/International
Society on Biomedical Research on Alcoholism interview
schedule, the study population was divided into three
groups: “nondrinker” (n = 623), indicated to be totally
abstinent or one who drinks alcohol only on special oc-
casions; “light/moderate drinker” (n = 63), one who
drinks <30 g ethanol/day for men or <20 g ethanol/day
for women; “heavy drinker” (n = 78), one who drinks >30 g
ethanol/day for men or >20 g ethanol/day for women.
The first two groups were used to establish reference
CDT levels. They were further divided into six groups
according to gender and age to evaluate the influence
of these parameters on CDT levels. The second and third
groups were used to show the relationship between
alcohol intake and CDT level, and to establish the CDT





(N = 623) (N = 141)
Age (years) 17-85 23-67
Average age (years) 45.17 49.11






Heart disease 13 5
Respiratory diseases 12 10
Renal disease 10 0
Thyroid illness 8 0
Alcohol consumption
(g/day)
0 623 (100.00%) 0 (0.00%)
1-15 0 (0.00%) 31 (21.99%)
16-30 0 (0.00%) 32 (22.70%)
31-45 0 (0.00%) 28 (19.86%)
46-60 0 (0.00%) 28 (19.86%)
61-120 0 (0.00%) 12 (8.51%)
>120 0 (0.00%) 10 (7.08%)
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in Hock et al. [11]. The demographics of the study popula-
tion are given in Table 5.
In addition, three sample pools (P1, P2, and P3) were
used for the precision study. They were analyzed accord-
ing to the Clinical and Laboratory Standards Institute
(CLSI) EP-5 protocol. P1 was prepared to obtain a lower
normal CDT level (0.5%), P2 was prepared to obtain a
higher normal CDT level (0.7%), and P3 was prepared to
obtain a normal CDT level near the cut-off (1.5%). An-
other two samples, one with a low CDT level (0.6%) and
one with a high CDT level (8.2%), were prepared for the
CDT linearity measurements.
Venous blood samples were collected under fasting con-
ditions into vacutainer tubes (Becton Dickinson, USA)
containing no additives. Serum samples were prepared
5 min after collection by centrifugation at 3500 g and
stored at −80°C until testing, a condition under which
the transferrin glycoform pattern is known to be
stable [22,23].Analytical methods
CDT measurements and identification of transferrin gen-
etic variants were performed using the Capillarys 2capillary zone electrophoresis system (Sebia, France). This
instrument performs all operations automatically to obtain
a complete transferrin profile for quantitative analysis of
CDT. The transferrin isoforms, separated in silica capil-
laries according to their electrophoretic mobility, were
directly detected at an absorbance of 200 nm. Capillary
electrophoresis has three advantages: the genetic variants
of transferrin are detected, the relative CDT concentra-
tions (percentages of total transferrin) are given, and elec-
trophoresis curves are generated for easier and more
accurate data interpretation.
Precision
The intra-run and between-day precision studies were
carried out following CLSI EP5-A protocol using three
identical sample pools (P1, P2, and P3). The three sam-
ples were analyzed in duplicate 20 times per day to ob-
tain the intra-run precision. Concurrently, these samples
were analyzed in duplicate once per day over 20 con-
secutive days. The mean, standard deviation, and coeffi-
cient of variation (CV) were calculated for each sample.
Linearity
The linearity study was conducted following the CLSI
EP6-A protocol. The linearity of CDT measurements
was tested between CDT levels of 0.6% and 8.2%. The
analysis was performed by mixing variable volumes of
two samples containing the same total transferrin con-
centration (≈1.5 g/L). We calculated the theoretical %
CDT values in each dilution based on the original two
samples. Each analysis was performed in duplicate.
Statistical analysis
All statistical analyses were performed using SPSS 16.0
software and Microsoft Excel, with t-tests to assess dif-
ferences between mean values (P < 0.05 considered sta-
tistically significant) and analysis of variance (ANOVA)
to assess differences among groups (P < 0.05 considered
statistically significant).
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